Pseudomonas aeruginosa isolation is an important predictor for recurrent hemoptysis after bronchial artery embolization in patients with idiopathic bronchiectasis: a multicenter cohort study
Authors:
Open Access
- 18 March 2023
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 24 (1) , 1-12
Abstract
Background: Nearly half of bronchiectasis patients receiving bronchial artery embolization (BAE) still have recurrent hemoptysis, which may be life-threatening. Worse still, the underlying risk factors of recurrence remain unknown. Methods: A retrospective cohort was conducted of patients with idiopathic bronchiectasis who received BAE from 2015 to 2019 at eight centers. Patients were followed up for at least 24 months post BAE. Based on the outcomes of recurrent hemoptysis and recurrent severe hemoptysis, a Cox regression model was used to identify risk factors for recurrence. Results: A total of 588 individuals were included. The median follow-up period was 34.0 months (interquartile range: 24.3–53.3 months). The 1-month, 1-year, 2-year, and 5-year cumulative recurrent hemoptysis-free rates were 87.2%, 67.5%, 57.6%, and 49.4%, respectively. The following factors were relative to recurrent hemoptysis: 24-h sputum volume (hazard ratio [HR] = 1.99 [95% confidence interval [95% CI]: 1.25–3.15, p = 0.015]), isolation of Pseudomonas aeruginosa (HR = 1.50 [95% CI: 1.13–2.00, p = 0.003]), extensive bronchiectasis (HR = 2.00 [95% CI: 1.29–3.09, p = 0.002]), and aberrant bronchial arteries (AbBAs) (HR = 1.45 [95% CI: 1.09–1.93, p = 0.014]). The area under the receiver operating characteristic curve of the nomogram was 0.728 [95% CI: 0.688–0.769]. Conclusions: Isolation of Pseudomonas aeruginosa is an important independent predictor of recurrent hemoptysis. The clearance of Pseudomonas aeruginosa might effectively reduce the hemoptysis recurrence rate.Keywords
Funding Information
- Bethune Charitable Foundation (BJ-RW2020001J)
- National Natural Science Foundation of China (81925001)
- the Innovation Program of Shanghai Municipal Education Commission (202101070007-E00097)
- Program of Shanghai Municipal Science and Technology Commission (21DZ2201800)
This publication has 37 references indexed in Scilit:
- Non CF-bronchiectasis: Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patientsRespiratory Medicine, 2016
- Aetiology and clinical characteristics of patients with bronchiectasis in a Chinese Han population: A prospective studyRespirology, 2015
- Haemoptysis in adults: a 5-year study using the French nationwide hospital administrative databaseEuropean Respiratory Journal, 2015
- Aetiology of bronchiectasis in Guangzhou, southern ChinaRespirology, 2015
- A Randomized Controlled Trial of Nebulized Gentamicin in Non–Cystic Fibrosis BronchiectasisAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Immediate and long-term outcomes of bronchial and non-bronchial systemic artery embolisation for the management of haemoptysisEuropean Radiology, 2009
- Massive haemoptysis: the definition should be revisedEuropean Respiratory Journal, 2008
- Hemoptysis: Bronchial and Nonbronchial Systemic Arteries at 16–Detector Row CTRadiology, 2005
- Cystic fibrosis: scoring system with thin-section CT.Radiology, 1991
- The developing bronchial arteries in a fetus of the twelfth weekJournal of Anatomy, 1970